Journal of the Society for Gynecologic Investigation

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/rsci

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scoccia, B.
Right arrow Articles by Ilekis, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of the Society for Gynecologic Investigation, Vol. 5, No. 3, 161-165 (1998)
DOI: 10.1177/107155769800500310
© 1998 SAGE Publications

Expression of the ErbB Family of Receptors in Ovarian Cancer

Bert Scoccia, MD

Young Mi Lee, MD

Craig Niederberger, MD

Departments of Obstetrics and Gynecology and Urology, University of Illinois at Chicago, College of Medicine. Chicago. Illinois

John V. Ilekis, PhD

Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology (MC 808). University of Illinois at Chicago, College of Medicine, 820 South Wood St., Chicago, IL 60621 ilekis{at}uic.edu

Objective: To characterize the relative levels of the ErbB family of receptors and their relationship to one another in ovarian cancer.

Methods: A total of 17 serous cystadenocarcinonas were analyzed for epidermal growth factor receptor (EGF-R or ErbB-1) and ErbB-2, ErB-3, and ErbB-4 receptor expression by Western blot analysis. Receptor levels were quantified by densitometry and expressed as relative densitometry units nomalized to the level of {alpha}-tubulin. Linear regression analysis was used to analyze receptor group differences. A value of P ≤ .05 was considered statistically significant.

Results: All 17 tumors expressed detectable levels of EGF-R, ErbB-2, and ErbB-3, but ErbB-4 expression was not detected. EGF-R levels correlated with ErbB-2 (r = .70, P < .01) and ErbB-3 (r= .52, P < .05) levels. The highest correlation was obtained between the levels of ErbB-2 and ErbB-3 (r = 0.81, P < .001).

Conclusion: This study indicates an association between the levels of ErbB receptor family members in ovarian cancer. This association suggests that one or more coordinated regulatory mechanisms may be involved in determining their relative expression levels to one another.

Key Words: Ovarian cancer • ErbB • growth factor receptors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?